Unichem Laboratories rose 3.40% to Rs 154.95 after the company announced the receipt of ANDA approval for Buspirone Hydrochloride Tablets USP from the USFDA.
Unichem Laboratories announced that it has received ANDA approval for its Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg, and 30 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bristol-Myers Squibb Company (BMS), Buspar Tablets, 5 mg, 10 mg, 15 mg, and 30 mg.
Buspirone Hydrochloride Tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. The product will be commercialized from Unichem's Ghaziabad Plant.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
